Recent 8-K filings for CNTB

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 13:02 UTC earnings item 2.02item 9.01

  Connect Biopharma reports Q1 net loss $19.4M; Phase 2 studies on track, topline data mid-2026

source · CNTB on sec.gov